Red Capital (Japan) Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
2
- Investments
-
3
- Portfolio
-
3
Red Capital (Japan) General Information
Company Description
Founded in 2024, Red Capital is a venture capital firm based in Tokyo, Japan. The firm seeks to invest in biotech, medtech, and digital health sectors.
Business Details
Website
www.redcapital.vcYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Ebisu Garden Place Tower 18th floor
- 20-3 Ebisu 4-chome, Shibuya-ku
- Tokyo
- Japan
Red Capital (Japan) Investments (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| SiccaNova Therapeutics | 03-Sep-2026 | Early Stage VC | Drug Discovery | Startup | ||
| Neusignal Therapeutics | 30-Jun-2026 | Drug Discovery | Generating Revenue | |||
| N.B.Medical | 05-Mar-2026 | Surgical Devices | Generating Revenue |
Red Capital (Japan) Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Red Capital (Japan) Co-Investors (25)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Mitsubishi UFJ Capital | 2 |
|
|
||
| DCI Partners |
|
|
|||
| Jafco |
|
|
|||
| Nippon Venture Capital |
|
|
|||
| Nissay Capital |
|
|
Red Capital (Japan) FAQs
-
What is Red Capital (Japan)?
Founded in 2024, Red Capital is a venture capital firm based in Tokyo, Japan.
-
When was Red Capital (Japan) founded?
Red Capital (Japan) was founded in 2024.
-
Where is Red Capital (Japan) headquartered?
Red Capital (Japan) is headquartered in Tokyo, Japan.
-
How many investments has Red Capital (Japan) made?
Red Capital (Japan) has made 3 investments.
-
What has Red Capital (Japan) invested in?
Red Capital (Japan) has made numerous investments in companies like SiccaNova Therapeutics, Neusignal Therapeutics, and N.B.Medical within the Drug Discovery and Surgical Devices industries.
-
What has Red Capital (Japan) invested in recently?
Red Capital (Japan)'s latest investment was on 03-Sep-2026 in SiccaNova Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
